Therefore, we hypothesized that SGLT2 inhibitors could suppress allergic asthma by suppressing inflammatory immune responses, and investigated it using an ovalbumin (OVA)-induced allergic asthma model in BALB/c mice. Here, SLC5A2 is linked to allergic asthma.